Compumedics Limited (ASX:CMP)

Market Cap	70.92M +35.4%
Revenue (ttm)	51.04M +1.5%
Net Income	-1.27M
EPS	-0.01
Shares Out	199.76M
PE Ratio	n/a
Forward PE	23.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	69,462
Average Volume	78,986
Open	0.3750
Previous Close	0.3750
Day's Range	0.3550 - 0.3750
52-Week Range	0.2400 - 0.4500
Beta	0.28
RSI	50.33
Earnings Date	Feb 22, 2026

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory stud...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 175
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CMP

Financial Performance

In fiscal year 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 275.1% more than in 2024.